1
|
Blümel JE, Arteaga E, Mezones-Holguín E, Zúñiga MC, Witis S, Vallejo MS, Tserotas K, Sánchez H, Onatra W, Ojeda E, Mostajo D, Monterrosa A, Lima S, Martino M, Hernández-Bueno JA, Gómez G, Espinoza MT, Flores D, Chedraui P, Calle A, Bravo LM, Benítez Z, Bencosme A, Barón G. Obesity is associated with a higher prevalence of musculoskeletal pain in middle-aged women. Gynecol Endocrinol 2017; 33:378-382. [PMID: 28084176 DOI: 10.1080/09513590.2016.1269741] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
Musculoskeletal pain (MSP) has been recently linked with high plasma leptin levels. Our objective was to study if obese women, who have higher leptin levels, could have a higher frequency of MSP. We studied 6079 Latin-American women, 40-59 years old. Their epidemiological data were recorded and the Menopause Rating Scale (MRS), Golberg Anxiety and Depression Scale and Insomnia Scale were applied. MSP was defined as a score ≥2 on MRS11. Women with MSP were slightly older, had fewer years of schooling and were more sedentary. They also complained of more severe menopausal symptoms (29.2% versus. 4.4%, p < 0.0001). Furthermore, they had a higher abdominal perimeter (87.2 ± 12.0 cm versus 84.6 ± 11.6 cm, p < 0.0001) and a higher prevalence of obesity (23.1% versus 15.2%, p < 0.0001). Compared to normal weight women, those with low body weight (IMC <18.5) showed a lower risk of MSP (OR 0.71; 95%CI, 0.42-1.17), overweight women had a higher risk (OR 1.64; 95%CI, 1.44-1.87) and obese women the highest risk (OR 2.06; 95%CI, 1.76-2.40). Logistic regression analysis showed that obesity is independently associated to MSP (OR 1.34; 95%CI, 1.16-1.55). We conclude that obesity is one identifiable risk factor for MSP in middle-aged women.
Collapse
Affiliation(s)
- Juan Enrique Blümel
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
- b Departamento de Medicina Interna Sur , Facultad de Medicina, Universidad de Chile , Santiago de Chile , Chile , and
| | - Eugenio Arteaga
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
- c Department of Endocrinology , School of Medicine, Pontificia Universidad Catolica de Chile , Santiago de Chile , Chile
| | - Edward Mezones-Holguín
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - María Cristina Zúñiga
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Silvina Witis
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - María Soledad Vallejo
- b Departamento de Medicina Interna Sur , Facultad de Medicina, Universidad de Chile , Santiago de Chile , Chile , and
| | - Konstantino Tserotas
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Hugo Sánchez
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - William Onatra
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Eliana Ojeda
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Desiree Mostajo
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Alvaro Monterrosa
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Selva Lima
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Mabel Martino
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | | | - Gustavo Gómez
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - María Teresa Espinoza
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Daniel Flores
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Peter Chedraui
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Andrés Calle
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Luz María Bravo
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Zully Benítez
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Ascanio Bencosme
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| | - Germán Barón
- a Collaborative Group for Research of the Climacteric in Latin America (REDLINC) , Santiago , Chile
| |
Collapse
|
2
|
Vallejo MS, Witis S, Ojeda E, Mostajo D, Morera F, Meruvia N, Martino M, Lima S, Espinoza M, Castillo O, Campostrini B, Danckers L, Blümel JE, Tserotas K, Sánchez H, Salinas C, Saavedra J, Rojas JA, Onatra W, Monterrosa A, Montaño A, Martínez J, González E, Gómez G, Calle A, Broutin G, Bencosme A, Arteaga E, Ayala F, Chedraui P. Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy? Climacteric 2016; 19:387-92. [DOI: 10.1080/13697137.2016.1191460] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- M. S. Vallejo
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - S. Witis
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - E. Ojeda
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - D. Mostajo
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - F. Morera
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - N. Meruvia
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - M. Martino
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - S. Lima
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - M.T. Espinoza
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - O. Castillo
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - B. Campostrini
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - L. Danckers
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - J. E. Blümel
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
- Departamento de Medicina Interna Sur, Facultad de Medicina, Universidad de Chile, Santiago de Chile, Chile
| | - K. Tserotas
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - H. Sánchez
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - C. Salinas
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - J. Saavedra
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - J. A. Rojas
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - W. Onatra
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - A. Monterrosa
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - A. Montaño
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - J. Martínez
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - E. González
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - G. Gómez
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - A. Calle
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - G. Broutin
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - A. Bencosme
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - E. Arteaga
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - F. Ayala
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | - P. Chedraui
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
- Institute of Biomedicine, Research Area for Women’s Health, Facultad de Ciencias Médicas, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador
| |
Collapse
|
3
|
Danckers L, Blümel JE, Witis S, Vallejo MS, Tserotas K, Sánchez H, Salinas C, Saavedra J, Rojas JA, Onatra W, Ojeda E, Mostajo D, Morera F, Monterrosa A, Montaño A, Meruvia N, Martino M, Martínez J, Lima S, González E, Gómez G, Espinoza MT, Castillo O, Campostrini B, Calle A, Broutin G, Bencosme A, Arteaga E, Ayala F, Chedraui P. Personal and professional use of menopausal hormone therapy among gynecologists: A multinational study (REDLINC VII). Maturitas 2016; 87:67-71. [PMID: 27013290 DOI: 10.1016/j.maturitas.2016.02.015] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2016] [Revised: 02/09/2016] [Accepted: 02/25/2016] [Indexed: 12/01/2022]
Abstract
BACKGROUND Previously, the REDLINC VI study showed that the main reason for the low use of menopausal hormone therapy (MHT) was its low rate of prescription by doctors. OBJECTIVE To determine the use of MHT and perceived related risks among gynecologists. METHODS A self-administered and anonymous questionnaire was delivered to certified gynecologists in 11 Latin American countries. RESULTS A total of 2154 gynecologists were contacted, of whom 85.3% responded to the survey (n = 1837). Mean age was 48.1 ± 11.4 years; 55.5% were male, 20.3% were faculty members and 85% had a partner. Overall, 85.4% of gynecologists responded that they would use MHT if they had menopausal symptoms (81.8% in the case of female gynecologists) or prescribe it to their partner (88.2% in the case of male gynecologists; p < 0.001). Perceived risk related to MHT use (on a scale from 0 to 10) was higher among female than among male gynecologists (4.06 ± 2.09 vs. 3.83 ± 2.11, p < 0.02). The top two perceived reported risks were thromboembolism (women 33.6% vs. men 41.4%, p < 0.009) and breast cancer (women 38.5% vs. men 33.9%, p < 0.03). Overall, gynecologists reported prescribing MHT to 48.9% of their symptomatic patients (women 47.3% vs. men 50.2%, p < 0.03) and 86.8% currently prescribed non-hormonal remedies and 83.8% alternative therapies for the management of the menopause. Gynecologists who were older and academic professionals prescribed MHT more often. CONCLUSION Although this Latin American survey showed that gynecologists are mostly supporters of MHT use (for themselves or their partners), this is not necessarily reflected in their clinical practice.
Collapse
Affiliation(s)
- Luis Danckers
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Juan E Blümel
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile; Departamento de Medicina Interna Sur, Facultad de Medicina, Universidad de Chile, Santiago, Chile
| | - Silvina Witis
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - María S Vallejo
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Konstantino Tserotas
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Hugo Sánchez
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Carlos Salinas
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Javier Saavedra
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - José A Rojas
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - William Onatra
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Eliana Ojeda
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Desireé Mostajo
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Flory Morera
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Alvaro Monterrosa
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Armando Montaño
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Nelva Meruvia
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Mabel Martino
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Jaime Martínez
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Selva Lima
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Erik González
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Gustavo Gómez
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - María T Espinoza
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Olivia Castillo
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Blanca Campostrini
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Andrés Calle
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Gerardo Broutin
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Ascanio Bencosme
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Eugenio Arteaga
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Félix Ayala
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile
| | - Peter Chedraui
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago, Chile; Institute of Biomedicine, Research Area for Women's Health, Facultad de Ciencias Médicas, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador.
| |
Collapse
|
4
|
Blümel JE, Chedraui P, Aedo S, Fica J, Mezones-Holguín E, Barón G, Bencosme A, Benítez Z, Bravo LM, Calle A, Flores D, Espinoza MT, Gómez G, Hernández-Bueno JA, Laribezcoa F, Martino M, Lima S, Monterrosa A, Mostajo D, Ojeda E, Onatra W, Sánchez H, Tserotas K, Vallejo MS, Witis S, Zúñiga MC. Obesity and its relation to depressive symptoms and sedentary lifestyle in middle-aged women. Maturitas 2014; 80:100-5. [PMID: 25459364 DOI: 10.1016/j.maturitas.2014.10.007] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2014] [Revised: 10/14/2014] [Accepted: 10/16/2014] [Indexed: 02/03/2023]
Abstract
BACKGROUND The prevalence of obesity increases during female mid-life and although many factors have been identified, data from Latin America is lacking. OBJECTIVE To assess factors related to obesity among middle-aged women and determine the association with depressive symptoms, sedentary lifestyle and other factors. METHODS A total of 6079 women aged 40-59 years of 11 Latin American countries were asked to fill out the Goldberg Anxiety and Depression Scale, the Menopause Rating Scale, the Athens Insomnia Scale, the Pittsburgh Sleep Quality Index and a general questionnaire containing personal socio-demographic data, anthropometric measures and lifestyle information. Obesity was defined as a body mass index (BMI) ≥30 kg/m(2). RESULTS Obesity was observed in 18.5% and sedentary lifestyle in 63.9%. A 55.5% presented vasomotor symptoms, 12.2% had severe menopausal symptoms and 13.2% used hormone therapy for the menopause. Prevalence of depressive symptoms was 46.5% and anxiety 59.7%. Our logistic regression model found that significant factors associated to obesity included: arterial hypertension (OR: 1.87), depressive symptoms (OR: 1.57), sedentary lifestyle (OR: 1.50) diabetes mellitus (OR: 1.34), higher number of individuals living at home (OR: 1.31), sleep problems (OR:1.22), anxiety (OR: 1.21), having a stable partner (OR: 1.20), parity (OR: 1.16) and vasomotor symptoms (OR:1.14). A lower risk for obesity was found among women using hormonal contraceptives (OR: 0.69). CONCLUSION Obesity in middle-aged women is the consequence of the interaction of multiple factors. It was associated to hypertension, depressive symptoms, sedentary lifestyle, climacteric symptoms and other factors.
Collapse
Affiliation(s)
- Juan E Blümel
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile; Departamento Medicina Sur, Facultad de Medicina, Universidad de Chile Orquídeas 1068, Dpto 302 PO Box 7510258, Providencia, Santiago de Chile, Chile.
| | - Peter Chedraui
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile; Institute of Biomedicine, Research Area for Women's Health, Facultad de Ciencias Médicas, Universidad Católica de Santiago de Guayaquil, Av. Carlos J Arosemena km 1.5, PO Box 09-01-4671, Guayaquil, Ecuador
| | - Sócrates Aedo
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile; Departamento Medicina Sur, Facultad de Medicina, Universidad de Chile Orquídeas 1068, Dpto 302 PO Box 7510258, Providencia, Santiago de Chile, Chile
| | - Juan Fica
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Edward Mezones-Holguín
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Germán Barón
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Ascanio Bencosme
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Zully Benítez
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Luz M Bravo
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Andrés Calle
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Daniel Flores
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - María T Espinoza
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Gustavo Gómez
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - José A Hernández-Bueno
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Fiorella Laribezcoa
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Mabel Martino
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Selva Lima
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Alvaro Monterrosa
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Desiree Mostajo
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Eliana Ojeda
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - William Onatra
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Hugo Sánchez
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Konstatinos Tserotas
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - María S Vallejo
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - Silvina Witis
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| | - María C Zúñiga
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC), Santiago de Chile, Chile
| |
Collapse
|
5
|
Blümel JE, Chedraui P, Barón G, Benítez Z, Flores D, Espinoza MT, Gomez G, González E, Hernández L, Lima S, Martino M, Montaño A, Monterrosa A, Mostajo D, Ojeda E, Onatra W, Robles C, Saavedra J, Sánchez H, Tserotas K, Vallejo MS, Vallejo C. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI). Climacteric 2014; 17:433-41. [PMID: 24443950 DOI: 10.3109/13697137.2014.882305] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
BACKGROUND Menopausal hormone therapy (HT) has shown benefits for women; however, associated drawbacks (i.e. risks, costs, fears) have currently determined its low use. OBJECTIVE To determine the prevalence of current HT use among mid-aged women and describe the characteristics of those who have never used, have abandoned or are currently using HT. In addition, reasons for not using HT were analyzed. METHOD This was a cross-sectional study that analyzed a total of 6731 otherwise healthy women (45-59 years old) of 15 cities in 11 Latin American countries. Participants were requested to fill out the Menopause Rating Scale (MRS) and a questionnaire containing sociodemographic data and items regarding the menopause and HT use. RESULTS The prevalence of current HT use was 12.5%. Oral HT (43.7%) was the most frequently used type of HT, followed by transdermal types (17.7%). The main factors related to the current use of HT included: positive perceptions regarding HT (odds ratio (OR) 11.53, 95% confidence interval (CI) 9.41-14.13), being postmenopausal (OR 3.47, 95% CI 2.75-4.36) and having a better socioeconomic level. A total of 48.8% of surveyed women had used HT in the past, but abandoned it due to symptom improvement or being unconcerned; fear of cancer or any other secondary effects were also reported but in less than 10%. Among women who had never used HT, 28% reported the lack of medical prescription as the main reason, followed by the absence of symptoms (27.8%). Among those reporting lack of prescription as the main reason for not using HT, 30.6% currently had severe menopausal symptoms (total MRS score > 16); 19.5% of women were using alternative 'natural' therapies, with 35.1% of them displaying severe menopausal symptoms as compared to a 22.5% observed among current HT users. CONCLUSION The use of HT has not regained the rates observed a decade ago. Positive perceptions regarding HT were related to a higher use. Lack of medical prescription was the main reason for not using HT among non-users, many of whom were currently displaying severe menopausal symptoms.
Collapse
|
6
|
Alarcón Galeano AM, Buitrago Hernández DF, Romero Fierro LA, Sánchez Leyva AM, Onatra W, Ríos MT. Efecto de la avena y/o lovastatina sobre el perfil lipídico en pacientes dislipidémicos del hospital de Tunjuelito, Bogotá 2008-2009. Rev U D C A Act & Div Cient 2013. [DOI: 10.31910/rudca.v16.n2.2013.903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
7
|
Monterrosa-Castro A, Blümel JE, Portela-Buelvas K, Mezones-Holguín E, Barón G, Bencosme A, Benítez Z, Bravo LM, Calle A, Chedraui P, Flores D, Espinoza MT, Gómez G, Hernández-Bueno JA, Laribezcoa F, Lima S, Martino M, Mostajo D, Ojeda E, Onatra W, Sánchez H, Navarro D, Tserotas K, Vallejo MS, Witis S, Zuñiga MC. Type II diabetes mellitus and menopause: a multinational study. Climacteric 2013; 16:663-72. [DOI: 10.3109/13697137.2013.798272] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
8
|
Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Tserotas K, Vallejo MS. Menopause could be involved in the pathogenesis of muscle and joint aches in mid-aged women. Maturitas 2013; 75:94-100. [DOI: 10.1016/j.maturitas.2013.02.012] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2013] [Revised: 02/19/2013] [Accepted: 02/22/2013] [Indexed: 01/01/2023]
|
9
|
Blümel JE, Cano A, Mezones-Holguín E, Barón G, Bencosme A, Benítez Z, Bravo LM, Calle A, Flores D, Espinoza MT, Gómez G, Hernández-Bueno JA, Laribezcoa F, Martino M, Lima S, Monterrosa A, Mostajo D, Ojeda E, Onatra W, Sánchez H, Tserotas K, Vallejo MS, Witis S, Zúñiga MC, Chedraui P. A multinational study of sleep disorders during female mid-life. Maturitas 2012; 72:359-66. [PMID: 22717489 DOI: 10.1016/j.maturitas.2012.05.011] [Citation(s) in RCA: 102] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2012] [Revised: 05/23/2012] [Accepted: 05/24/2012] [Indexed: 11/28/2022]
Abstract
BACKGROUND Although sleep disturbances are common during female mid-life, few studies have described in detail the prevalence of this problem and related risk factors. OBJECTIVE To determine the prevalence of sleep disturbances in mid-aged women using validated tools. Assessment of determinants capable of influencing the prevalence of insomnia and poor sleep quality was also performed. METHODS A total of 6079 women aged 40-59 of 11 Latin American countries were invited to fill out the Athens Insomnia Scale (AIS), the Pittsburgh Sleep Quality Index (PSQI), the Goldberg Anxiety and Depression Scale, the Menopause Rating Scale (MRS), the Brief Scale of Abnormal Drinking and a general socio-demographic questionnaire. RESULTS Overall, 56.6% of surveyed women suffered of either insomnia, poor sleep quality, or both. Specifically, 43.6% and 46.2% presented insomnia and poor sleep quality in accordance to the AIS and the PSQI respectively. The prevalence of insomnia increased with female age (from 39.7% in those aged 40-44 to 45.2% in those aged 55-59, p<0.0001) and menopausal stage (from 39.5% in premenopausal aged 40-44 to 46.3% in late postmenopausal ones, p<0.0001). "Awakening during the night" (AIS: Item 2) was the most highly rated of all items and contributing in a higher degree (mean 16%) to the total score of the scale in all menopausal phases. Sleep quality also worsened with age and menopausal status, impairment particularly affecting sleep efficiency and latency and the increased use of hypnotics. Vasomotor symptoms (VMS), depressive mood and anxiety were associated to sleep disturbances. Women presenting sleep disturbances displayed a 2-fold increase in the severity of menopausal symptoms (higher total MRS scores) which was translated into a 6-8 times higher risk of impaired quality of life. Logistic regression analysis determined that female age, the presence of chronic disease, troublesome drinking, anxiety, depression, VMS, drug use (hypnotics and hormone therapy) were significant risk factors related to the presence of sleep disturbances. Higher educational level related to less insomnia and better sleep quality. CONCLUSION Insomnia and poor sleep quality were highly prevalent in this mid-aged female sample in which the influence of age and the menopause was only modest and rather linked to menopausal symptoms already occurring since the premenopause.
Collapse
Affiliation(s)
- Juan E Blümel
- Collaborative Group for Research of the Climacteric in Latin America (REDLINC)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Tserotas K, Vallejo MS. Menopausal symptoms appear before the menopause and persist 5 years beyond: a detailed analysis of a multinational study. Climacteric 2012; 15:542-51. [DOI: 10.3109/13697137.2012.658462] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
11
|
Onatra W, Vargas S, Páez E, Rojas D, López A. Correlación entre la enfermedad respiratoria aguda (ERA) en mujeres embarazadas y la calidad del aire. Rev U D C A Act & Div Cient 2009. [DOI: 10.31910/rudca.v12.n2.2009.689] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
12
|
Royer M, Castelo-Branco C, Blümel JE, Chedraui PA, Danckers L, Bencosme A, Navarro D, Vallejo S, Espinoza MT, Gómez G, Izaguirre H, Ayala F, Martino M, Ojeda E, Onatra W, Saavedra J, Tserotas K, Pozzo E, Manriquez V, Prada M, Grandia E, Zuniga C, Lange D, Sayegh F. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric 2009; 10:164-70. [PMID: 17453865 DOI: 10.1080/13697130701258895] [Citation(s) in RCA: 66] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
BACKGROUND Metabolic syndrome (METS) is a strong predictor of cardiovascular risk. Since the prevalence of METS increases after menopause, gynecological routine consultation offers an excellent screening opportunity. OBJECTIVES To assess the prevalence of METS in Latin American postmenopausal women and factors modifying its risk; as well as to assess the role of simple routine care measurements in the diagnosis of the METS. METHODS A total of 3965 postmenopausal women, aged 45-64 years, seeking health care at 12 gynecological centers in major Latin American cities were included in this cross-sectional study. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) guidelines were applied to assess METS. This was present if three or more of the following conditions were present: waist circumference > or = 88 cm; blood pressure > or = 130/85 mmHg; fasting plasma triglycerides > or = 150 mg/dl; high density lipoprotein (HDL) cholesterol < 50 mg/dl; glucose > or = 110 mg/dl or subjects were receiving treatment for their condition. RESULTS The prevalences of having at least two, three, four or five components were 62.5, 35.1, 13.5 and 3.2%, respectively. The prevalence increased from 28.1% in those aged 40-44 years to 42.9% in those aged 60-64 years. The risk of METS detection (multivariate analysis) increased with age (odds ratio (OR) 1.22, 95% confidence interval (CI) 1.03-1.43), time elapsed since menopause (OR 1.18, 95% CI 1.00-1.38), smoking cigarettes (OR 1.40, 95% CI 1.19-1.65), obesity (OR 13.01, 95% CI 10.93-15.49) and hypertension (OR 9.30, 95% CI 7.91-10.94). In contrast, hormone therapy reduces this risk (OR 0.59, 95% CI 0.51-0.70). CONCLUSION There is a high prevalence of the metabolic syndrome in postmenopausal Latin American women seeking gynecologic health care. Age, years since menopause, obesity and hypertension are strong predictors of this condition.
Collapse
|
13
|
Chedraui P, Blümel JE, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Tserotas K. Impaired quality of life among middle aged women: A multicentre Latin American study. Maturitas 2008; 61:323-9. [DOI: 10.1016/j.maturitas.2008.09.026] [Citation(s) in RCA: 80] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2008] [Revised: 09/23/2008] [Accepted: 09/24/2008] [Indexed: 10/21/2022]
|
14
|
Vargas S, Onatra W, Osorno L, Páez E, Sáenz O. Contaminación atmosférica y efectos respiratorios en niños, en mujeres embarazadas y en adultos mayores. Rev U D C A Act & Div Cient 2008. [DOI: 10.31910/rudca.v11.n1.2008.600] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
15
|
Alwers R, Urdinola J, Onatra W, Sánchez F, Posso H. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate). Maturitas 1999; 32:41-50. [PMID: 10423715 DOI: 10.1016/s0378-5122(99)00013-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVES To compare the effect on plasma lipids of conjugated estrogens/medroxyprogesterone acetate (CE/MPA) and estradiol valerate/cyproterone acetate (EV/CPA) in healthy peri and postmenopausal women during 1 year. METHODS Multicentric, controlled, single blinded Phase III clinical trial. Women were randomized to two treatment groups: Group A (n = 49 women): CE 0.625 mg/day for 21 days and MPA 5 mg from day 12 to 21. Group B (n = 55 women): EV 2 mg/day for 21 days and CPA 1 mg from day 12 to 21. Total cholesterol (TC), high density cholesterol (HDL-C), low density cholesterol (LDL-C), triglycerides, aminotransferases and alkaline phosphatase were measured before starting therapy, and after 3, 6, 9 and 12 months of hormone replacement therapy (HRT). TC/HDL-C and LDL-C/HDL-C ratios were determined. RESULTS There were no changes in TC levels. HDL-C increased and LDL-C decreased significantly, with no differences between groups but within each group. Triglycerides increased significantly but remained within normal values, with no differences between groups. TC/HDL-C ratio showed a slight and steady decrease in both groups. LDL-C/HDL-C ratio decreased in both treatment groups. CONCLUSION Both cyclic sequential preparations used in HRT showed a favorable effect on plasma lipids in healthy peri and postmenopausal women, with an increase in HDL-C and a decrease in LDL-C levels, as well as in the LDL-C/HDL-C and TC/HDL-C ratios. Our study confirms the positive effect of estrogens on lipids, which does not seem to be adversely affected by the addition of progestogens derived from pregnanes.
Collapse
Affiliation(s)
- R Alwers
- Department of Internal Medicine, Hospital Santa Clara, Schering Colombiana S.A., Santafé de Bogotá, Colombia.
| | | | | | | | | |
Collapse
|
16
|
Onatra W. The use of arachidonic acid in some gynaecological disorders. Pharmacol Toxicol 1994; 75 Suppl 2:83-5. [PMID: 7816791 DOI: 10.1111/j.1600-0773.1994.tb02006.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- W Onatra
- Department of Obstetrics and Gynaecology, National University of Columbia Endocrinology and Gynaecology Service, Bogotá
| |
Collapse
|